Clinical trialPhase 3
OCEAN(a)-Outcomes
NCT05581303
Randomized placebo-controlled, N≈7 297, established ASCVD + Lp(a) ≥200 nmol/L.
Also in the catalogue
- ACCLAIM-Lp(a)Clinical trial
- Lp(a)HORIZON (pelacarsen)Clinical trial
- PelacarsenDrug
- CORALreef OutcomesClinical trial
- ACCLAIM-CTAClinical trial
- BROADWAY (obicetrapib)Clinical trial
Scales
Identifiers
- NCT
- NCT05581303
Original sources
Details
- Phase
- Phase 3
- Status
- Active, not recruiting
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.